Xeljanz 5mg tablet

Xeljanz 5mg tablet targets inflammation present in rheumatoid arthritis by inhibiting the Janus kinase enzymes. These enzymes are involved in the inflammatory response pathway. Treatment with Xeljanz 5mg tablet is associated with dose-dependent increases in B cell counts. Changes in circulating T-lymphocyte counts and T-lymphocyte subsets (CD3+, CD4+, and CD8+) were small and inconsistent. After treatment with Xeljanz 5mg tablet in patients with rheumatoid arthritis, rapid decreases in serum C-reactive protein (CRP) were observed and maintained throughout dosing.
​

Following are the possible side effects that can occur during your treatment with the Xeljanz 5mg tablet. Contact your medical practitioner immediately if any of the above-mentioned side effects appear.

Bladder pain
Irregular heartbeat
Bloating
Diarrhea
Chills
Runny or stuffy nose
Nausea
Unusual tiredness
Headache
Dizziness
Fever
​

Xeljanz 5mg Tablet is used to treat certain types of arthritis (Psoriatic Arthritis, Rheumatoid Arthritis, and polyarticular course juvenile idiopathic arthritis-pcJIA). Xeljanz 5mg tablet also helps to block a certain enzyme in the body that affects the immune system. Take this tablet orally once a day with or without food. Regular monitoring of blood cell count, liver function, kidney function, and cholesterol levels is required during treatment with this medicine. Do not use Xeljanz 5mg Tablet (Tofacitinib) if you are pregnant.

It is advisable not to miss a dose. If you miss a scheduled dose of Xeljanz tablets, contact your doctor immediately.
​